A 20 kDa soluble Nogo-A fragment (an axonal growth inhibitor (Schwab, 2004) was recently found to be present in 96% of CSF samples from MS patients, but none of the control patients (Jurewicz et al., 2007). The gene discussed is RTN4; the disease is myeloid sarcoma.